All data are based on the daily closing price as of March 28, 2025
d
Daewoong pharmaceutical
069620.KO
79.40 USD
-2.10
-2.58%
Overview
Last close
79.40 usd
Market cap
913.60M usd
52 week high
119.39 usd
52 week low
72.15 usd
Target price
139.04 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.9422
Price/Book Value
1.6869
Enterprise Value
1.27B usd
EV/Revenue
1.3168
EV/EBITDA
16.65
Key financials
Revenue TTM
967.90M usd
Gross Profit TTM
498.83M usd
EBITDA TTM
132.13M usd
Earnings per Share
N/A usd
Dividend
0.41 usd
Total assets
1.34B usd
Net debt
368.41M usd
About
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.